Apoptosis in multiple sclerosis - Etiopathogenetic relevance and perspectives for new therapeutic strategies;Apoptose bei multipler sklerose. Atiopathogenetische relevanz und perspektiven fur neue therapeutische strategien

Nervenarzt

Volumn 71, Issue 10, 2000, Pages 767-773

  Aktas, O ^a   Wendling, U ^a   Zschenderlein, R ^a   Zipp, F ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Apoptosis; CD95; Immunopathogenesis; Multiple sclerosis; TNF

Indexed keywords

FAS ANTIGEN; TUMOR NECROSIS FACTOR;

APOPTOSIS; ARTICLE; DISEASE ASSOCIATION; GLIA CELL; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; IMMUNOPATHOGENESIS; LYMPHOCYTE COUNT; MULTIPLE SCLEROSIS; T LYMPHOCYTE ACTIVATION; TISSUE INJURY;

APOPTOSIS; AUTOANTIGENS; HUMANS; IMMUNOSUPPRESSION; LYMPHOCYTE ACTIVATION; MULTIPLE SCLEROSIS; MYELIN PROTEINS; NEUROGLIA; NEURONS; T-LYMPHOCYTES;

EID: 0033787406     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050664     Document Type: Article

References (38)

1. Impairmen: Of TNF-receptor-1 signaling but not Fas signaling diminishes T-cell apoptosis in myelin oligodendrocyte glycoprotein peptide-induced chronic demyelinating autoimmune encephalomyelitis in mice
2. FasL (CD95L,Apo1L) is expressed in the normal rat and human brain: Evidence for the existence of an immunological brain barrier
3. Multiple sclerosis: Oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis
4. Possible role of transforming growth factor-beta in relapsing-remitting multiple sclerosis
5. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule
6. Adoptively transferred EAE in mice bearing the Ipr mutation
7. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis
8. Multiple sclerosis: Fas signaling in oligodendrocyte cell death
9. Evidence for Fas-dependent and Fas-independent mechanisms in the pathogenesis of experimental autoimmune encephalomyelitis
10. Cell death and birth in multiple sclerosis brain
11. Up-regulated p75NTR neurotrophin receptor on glial cells in MS plaques
12. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain
13. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity
14. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein
15. T-cell apoptosis in autoimmune diseases: Termination of inflammation in the nervous system and other sites with specialized immunedefense mechanisms
16. Simultaneous increase in the percentage of apoptotic T helper cells and of activated T cells in patients with RRMS during therapy with Copaxone®
17. Interferon beta-1b augments activation-induced T-cell death in multiple sclerosis patients
18. Activated human T cells,B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: A neuroprotective role of inflammation?
19. Impaired apoptosis in mitogen-stimulated lymphocytes of patients with multiple sclerosis
20. Myelin oligodendrocyte glycoprotein-induced encephalomyelitis is chronic/relapsing in perforin knockout mice, but monophasic in Fas- and Fas ligand-deficient Ipr and gld mice
21. Therapeutic preparations of normal poly-specific IgG (IVIg) induce apoptosis in human lymphocytes and monocytes: A novel mechanism of action of IVIg involving the Fas a poptotic pathway
22. Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis
23. Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system
24. Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis: Evidence for programmed cell death as a mechanism to control inflammation in the brain
25. Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis
26. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
27. Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis
28. Transforming growth factor-beta2 induces a poptosis of routine T cell clones without down-regulating bcl-2 mRNA expression
29. Partial synergy of bisindolylmaleimide with apoptotic stimulus in antigen-specific T cells - Implications for multiple sclerosis
30. Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells
31. Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis
32. Bisindolylmaleimide VIII facilitates Fasmediated apoptosis and inhibits T cell-mediated autoimmune diseases
33. Apoptosis in multiple sclerosis
34. No induction of apoptosis by IFN-beta in human antigen-specific T cells
35. Immune (dys)regulation in multiple sclerosis: Role of the CD95/CD95 ligand system
36. Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand
37. Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing remitting multiple sclerosis